An open-label, uncontrolled, 8-week clinical trial of barnidipine hydrochloride, a once-daily calcium channel blocker, in Korean patients with essential hypertension

Authors
Category Primary study
JournalCurrent Therapeutic Research - Clinical and Experimental
Year 1997
This article has no abstract
Epistemonikos ID: e5428e7e3d3d01ebd793413ff3a8ac879267db62
First added on: Feb 03, 2025